Devyser: Next-Generation Diagnostics Company Put to the Test - Redeye

Redeye initiates coverage of Devyser, a rapidly growing Swedish diagnostics company that offers cutting-edge test kits in oncology, hereditary diseases, and post-transplantation monitoring. We believe the company is only at the start of its growth journey, moving even further beyond the impressive sales growth of the past five years, and we see it as a compelling investment at the current valuation.

Länk till analysen i sin helhet: https://www.redeye.se/research/837928/devyser-next-generation-diagnostics-company-put-to-the-test?utm_source=finwire&utm_medium=RSS